European guidelines require that all stakeholders in the supply chain of medicinal products comply with Good Distribution Practices. Sponsor companies of medicinal products must ensure that their products will be distributed under controlled conditions. This means that wholesalers, transport companies, warehouses and other partners in the supply chain must comply with these guidelines. GDP audits of these facilities can assist with managing these expectations. Our global auditing team can assist with GDP audits of:

• Distribution facilities including 3PL providers
• Warehouses and drug depots
• Transportation companies
• Wholesalers